|
Related Party Transactions
|
9 Months Ended | |||
|---|---|---|---|---|
|
Mar. 31, 2014
|
||||
| Related Party Transactions [Abstract] | ||||
| Related Party Transactions Disclosure [Text Block] |
In January 2012, the Company entered into an agreement with a vendor in which iBio’s President is a minority stockholder. The vendor performs laboratory feasibility analyses of gene expression, protein purification and preparation of research samples. The transaction has been conducted on an arm’s length basis at market terms. The accounts payable balance includes amounts due this vendor of approximately $37,000 and $93,000 at March 31, 2014 and June 30, 2013, respectively. Research and development expenses related to this vendor were approximately $124,000 and $82,000 for the three months ended March 31, 2014 and 2013, respectively, and approximately $430,000 and $301,000 for the nine months ended March 31, 2014 and 2013, respectively. |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|